Cognitive functions, quality of life in patients with dyscirculatory (vascular) encephalopathy II stage in northerners from the position of ICF

Objective. The aim of the study was to analyze cognitive functions, emotional disorders, the quality of life with the application of the International Classification of Functioning (ICF) in patients with chronic cerebrovascular diseases, dyscirculatory (vascular) encephalopathy II stage in the Komi Republic. Design and methods. In the clinics of the Komi Republic, we examined 126 people (mean age — 65,8 ± 10,1 years; women comprised 76 participants, 60,3 %, p ≤ 0,05) with dyscirculatory (vascular) encephalopathy. Complaints and anamnesis were analyzed, somatic and neurological status, cognitive functions, emotional status, and sleep were assessed. Results. Out of 126 patients, 44,5 % patients are employed (56 people). Among non-working patients with an established group of disability, 35,7 % (in 14,3 % disability 2^nd degree (10 people), in 21,4 % — disability 3^rd degree (15 people), p ≤ 0,05). Among the workers, 3 people (5,3%) had disability 3^rd degree. Hypertension (HTN) I stage was detected in 10,6 %, HTN II stage — in 44,4 %, HTN III stage — in 45 % (p ≤ 0,05); 27,8 % had history of ischemic heart disease, 7,2 % — myocardial infarction, 19,1% — cerebrovascular accident, 8,6% — heart rhythm disturbances, 15,8 % — significant stenosis of the brachiocephalic arteries. Based on memory function assessment by ICF, none demonstrated normal results. Mild cognitive impairment was usually found, and there was no case of dementia. Dysfunction in the domain of blood pressure function was found in all patients. The dysfunction of blood vessels was found in all patients with chronic cerebral ischemia II stage. Daily activities were reduced due to the physical dysfunction. According to the total assessment of health status by the SF-36 scale, the physical and mental components of health were similarly decreased. Conclusions. The SF-36 (questionnaire for assessing the quality of life) and ICF (International Classification of Functioning, Disabilities and Health) complement each other. Cognitive scales are the basic tools for examination of patients with chronic cerebral ischemia, making diagnosis according to ICF, and treating cognitive, physical and emotional disorders in dyscirculatory (vascular) encephalopathy.

1. Timonin SA, Papanina EK. Mortality from circulatory diseases in Russia and Moscow in the light of world trends. Moscow medicine. 2017;4 (19):57–63. In Russian.

2. Vishnevsky AG, Andreev EM, Timonin SA. Mortality from diseases of the circulatory system and life expectancy in Russia. Demographic Review. 2015; 3(1):6–34. In Russian.

3. Skvortsova VI, Stakhovskaya LV, Gudkova VV, Alekhin AV. Chronic cerebral circulation failure. Neurology. National textbook. Ed. by Gusev EI, Konovalov AN, Skvortsova VI, Gekht AB. M .: GEOTAR-Media, 2010. In Russian.

4. Shishkova VN. Cognitive impairment is a universal clinical syndrome in the practice of an internist. Center for Speech Pathology and Neurorehabilitation, Moscow. Toolkit. M., 2017. In Russian.

5. Yakovchuk ED, Penina GO. Neuropsychological status in northerners with stage II discirculatory encephalopathy, some pharmacoeconomic aspects of treatment. Materials of the 10th conference of neurologists of the Northwestern Federal District of the Russian Federation with international participation, April 6–7 2016. In Russian.

6. Bogolepova AN. Cognitive impairment in patients with cerebrovascular pathology. Treatment of Diseases of Neural System. 2011;3(8):16–22. In Russian.

7. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8(4):355–369.

8. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol. 2009;8(4):345–354.

9. Brevik EJ, Eikeland RA, Lundervold AJ. Subthreshold depressive symptoms have a negative impact on cognitive functioning in middle-aged and older males. Front Psychol. 2013;4:309.

10. Wesnes KA, Harrison JE. The evaluation of cognitive function in the dementias: methodological and regulatory considerations. Dialogues Clin Neurosci. 2003;5(1):77–88.

11. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43(2):250–260.

12. Hebert R, Lindsay J, Verreault R, Rockwood K, Hill G, Dubois MF. Vascular dementia: incidence and risk factors in the Canadian study of health and aging. Stroke. 2000;31(7):1487–1493.

13. International classification of functioning, disabilities and health: ICF. World Health Organization. Geneva. 2001. In Russian.

14. Lokshina AB, Zakharov VV. Practical algorithms for managing patients with chronic cerebral ischemia. Effektivnaya Farmakoterapiya = Effective Pharmacotherapy. 2019; 15(19):24–28. In Russian.

15. Kadykov AS, Manvelov LS, Shakhparonova NV. Chronic vascular diseases of the brain. Encephalopathy. 4th ed., Rev. and add. Moscow: GEOTAR-Media, 2018. P. 7. In Russian.

16. Levin OS, Shtulman DR. Neurology: a handbook of a practitioner. 11th ed., Rev. M.: MEDpress-inform, 2018. P. 58. In Russian.

17. Gusev EI, Bogolepova AN. Cognitive impairment in cerebrovascular diseases. 4th ed. M.: MEDpress-inform, 2014. In Russian.